Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.
Isaura S IbrahimCatharina BrücknerAlfredo CarratoJulie EarlAkin IndersonWouter H de Vos Tot Nederveen CappelIoannis MintzirasElvira MatthäiJens FigielMartin WasserHans MoreauBert BonsingEmily P SlaterDetlef K BartschHans Fa VasenPublished in: United European gastroenterology journal (2019)
The present study demonstrates that extrapancreatic incidentaloma is a common finding in IARs for PDAC, but rarely requires additional treatment. CDKN2A-p16-Leiden mutation carriers were the only patient group found to harbor a substantial number of cancers, and detection resulted in benefit in several cases.